Walgreens Boots Alliance Stock Forecast, Price & News

Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions

Is Walgreens Boots Alliance a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Walgreens Boots Alliance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View analyst ratings for Walgreens Boots Alliance or view top-rated stocks.

How has Walgreens Boots Alliance's stock price been impacted by COVID-19 (Coronavirus)?

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WBA stock has increased by 14.0% and is now trading at $52.50.
View which stocks have been most impacted by COVID-19.

When is Walgreens Boots Alliance's next earnings date?

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Wednesday, March 30th 2022.
View our earnings forecast for Walgreens Boots Alliance.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) released its earnings results on Thursday, January, 6th. The pharmacy operator reported $1.68 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.35 by $0.33. The pharmacy operator had revenue of $33.90 billion for the quarter, compared to analyst estimates of $32.87 billion. Walgreens Boots Alliance had a net margin of 4.76% and a trailing twelve-month return on equity of 20.28%. The company's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.22 earnings per share.
View Walgreens Boots Alliance's earnings history.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Wednesday, October 20th. Stockholders of record on Monday, November 15th will be given a dividend of $0.477 per share on Friday, December 10th. This represents a $1.91 annualized dividend and a dividend yield of 3.63%. The ex-dividend date is Friday, November 12th.
View Walgreens Boots Alliance's dividend history.

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance pays an annual dividend of $1.91 per share and currently has a dividend yield of 3.59%. Walgreens Boots Alliance has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Walgreens Boots Alliance is 25.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 37.60% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.
View Walgreens Boots Alliance's dividend history.

What price target have analysts set for WBA?

11 analysts have issued twelve-month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $48.00 to $68.00. On average, they expect Walgreens Boots Alliance's share price to reach $54.00 in the next year. This suggests a possible upside of 2.9% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance or view top-rated stocks among Wall Street analysts.

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the following people:

• Rosalind Gates Brewer, Chief Executive Officer & Director
• John Standley, President & Executive Vice President
• Ornella Barra, Chief Operating Officer
• James Kehoe, Global Chief Financial Officer & Executive VP
• Francesco Tinto, Global Chief Information Officer & Senior VP

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance CEO Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among Walgreens Boots Alliance's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Walgreens Boots Alliance's key competitors?

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Rite Aid (RAD), PetMed Express (PETS), 111 (YI), MedAvail (MDVL), Progressive Care (RXMD), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA), Dougherty's Pharmacy (MYDP), China Dasheng Biotechnology (CDBT), Dragon Jade International (DGJI) and Health Sciences Group (HESG).
View all of WBA's competitors.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by many different institutional and retail investors. Top institutional investors include Tandem Investment Advisors Inc. (0.11%), Russell Investments Group Ltd. (0.05%), Osher Van de Voorde Investment Management (0.04%), Armstrong Henry H Associates Inc. (0.03%), Kestra Advisory Services LLC (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Walgreens Boots Alliance stock include Marco Patrick Anthony Pagni and Nancy M Schlichting.
View institutional ownership trends for Walgreens Boots Alliance.

Which major investors are selling Walgreens Boots Alliance stock?

WBA stock was sold by a variety of institutional investors in the last quarter, including Moody National Bank Trust Division, Cardinal Capital Management Inc., Russell Investments Group Ltd., Pendal Group Ltd, Chesley Taft & Associates LLC, Retirement Systems of Alabama, IBM Retirement Fund, and Farmers & Merchants Investments Inc..
View insider buying and selling activity for Walgreens Boots Alliance or view top insider-selling stocks.

Which major investors are buying Walgreens Boots Alliance stock?

WBA stock was bought by a variety of institutional investors in the last quarter, including Clear Street Markets LLC, Tandem Investment Advisors Inc., Mountain Capital Investment Advisors Inc, Boenning & Scattergood Inc., Stonnington Group LLC, Sciencast Management LP, Fulton Bank N.A., and Bath Savings Trust Co.
View insider buying and selling activity for Walgreens Boots Alliance or or view top insider-buying stocks.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $52.50.

How much money does Walgreens Boots Alliance make?

Walgreens Boots Alliance has a market capitalization of $45.32 billion and generates $132.51 billion in revenue each year. The pharmacy operator earns $2.54 billion in net income (profit) each year or $7.42 on an earnings per share basis.

How many employees does Walgreens Boots Alliance have?

Walgreens Boots Alliance employs 315,000 workers across the globe.

Does Walgreens Boots Alliance have any subsidiaries?

The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare (Distribution) Limited, Alliance Healthcare Deutschland AG, Alliance Healthcare Ecza Deposu Anonim Şirketi, Alliance Healthcare España S.A., Alliance Healthcare Romania SRL, Alliance Healthcare Répartition, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Evolent Health, Farmacias Benavides S.A.B. de C.V., Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, United Company of Pharmacists SAE, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Boots Alliance Scottish LP, Walgreens Specialty Pharmacy LLC, Waltrust Properties Inc., and iA.

When was Walgreens Boots Alliance founded?

Walgreens Boots Alliance was founded in 2014.

What is Walgreens Boots Alliance's official website?

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

Where are Walgreens Boots Alliance's headquarters?

Walgreens Boots Alliance is headquartered at 108 Wilmot Road, Deerfield IL, 60015.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at (847) 315-3700, via email at [email protected], or via fax at 847-914-2804.